Duloxetine for Treatment of Painful Temporomandibular Joint Disorder.

Trial Profile

Duloxetine for Treatment of Painful Temporomandibular Joint Disorder.

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2017

At a glance

  • Drugs Duloxetine (Primary)
  • Indications Facial pain; Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Jun 2012 Actual end date (1 Dec 2011) added as reported by ClinicalTrials.gov.
    • 26 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Sep 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top